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Abstract
Background: Transmissible Spongiform Encephalopathies (TSEs) are a group of progressive fatal neurodegenerative
disorders, triggered by abnormal folding of the endogenous prion protein molecule. The encoding gene is a major
biological factor influencing the length of the asymptomatic period after infection. It remains unclear the extent to which
the variation between quantitative trait loci (QTLs) reported in mouse models is due to methodological differences between
approaches or genuine differences between traits. With this in mind, our approach to identifying genetic factors has sought
to extend the linkage mapping approach traditionally applied, to a series of additional traits, while minimising
methodological variability between them. Our approach allows estimations of heritability to be derived, as well as
predictions to be made about possible existence of genetic overlap between the various traits.
Methodology/Principal Findings: Our data indicate a surprising degree of heritability (up to 60%). Correlations between
traits are also identified. A series of QTLs on chromosomes 1, 2, 3, 4, 6, 11 and 18 accompany our heritability estimates.
However, only a locus on chromosome 11 has a general effect across all 4 models explored.
Conclusions/Significance: We have achieved some success in detecting novel and pre-existing QTLs associated with
incubation time. However, aside from the general effects described, the model-specific nature of the broader host genetic
architecture has also been brought into clearer focus. This suggests that genetic overlap can only partially account for the
general heritability of incubation time when factors, such as the nature of the TSE agent and the route of administration are
considered. This point is highly relevant to vCJD (a potential threat to public health) where the route of primary importance
is oral, while the QTLs being sought derive exclusively from studies of the ic route. Our results highlight the limitations of a
single-model approach to QTL-mapping of TSEs.
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Introduction
The Prnp locus has long been established as the major genetic
determinant of Transmissible Spongiform Encephalopathy (TSE)
incubation time, however its effects do not fully explain the
variance associated with this trait, thus other critical factors must
also play an important role in the aetiology of these disorders [1],
[2]. TSE pathogenesis has been shown to be heavily dependent on
intrinsic factors specific to the strain of the agent, the route of
transmission [3] and dose of infection [4]. Since the identification
of the prion protein gene, more recent studies have established
that the risk from acquired prions is mitigated by host genes other
than Prnp [2], [5]. Although incubation period phenotypes in the
TSEs are the product of multiple small gene effects, their overall
impact may be cumulatively substantial. Exactly how substantial
(ie. their collective heritability) is a question to date unexplored for
acquired TSEs on account of their rarity and the challenges posed
by their potentially long incubation periods. Prion research has
benefitted from the success of linkage studies conducted in the
mouse. These have highlighted several regions associated with the
incubation period phenotype [5]. Additionally a recent genome
wide association study of human TSEs cases conducted by Mead
et al [6] identified common variants for age of onset and death,
two corollaries of the incubation period phenotype.
The contrasting genetic approaches of linkage and association
are complementary and normally explore competing hypotheses
regarding the underlying genetic architecture of disease progres-
sion. They provide a means by which to interrogate the genome
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intermediate/large effects. Current evidence suggests that the two
models are not mutually exclusive and may coalesce [6], [7], [8].
Methodological variability precludes most meaningful compar-
isons between previous linkage efforts, as studies differ by either
the chosen genetic background, prion source, or the host
adaptation status of the agent [5]. However the frequency with
which QTLs have been successfully identified across these studies
advances the case for a genetic basis independent from Prnp while,
the variability between the loci reported gives some indication of
the scale on which influential variants may exist. However still this
leaves little objective rationale for distinguishing the more
empirically relevant loci from those whose effects are confined to
only certain genetic backgrounds.
In all, 5 previous linkage studies have implicated QTLs on 12
different chromosomes [5,7,8,9,10]. The more recurrent among
these loci such as chromosome 11, provide a stronger rationale for
targeted fine mapping approaches. These previous studies are all
based on intracranial (ic) transmission, which involves the
introduction of prion material directly to the brain. This paradigm
may model infection arising from exposure to larger peripheral
doses of infectivity, as the relatively long period of replication in
the spleen that would normally be seen in peripheral administra-
tion is bypassed in this instance, suggestive of direct neuroinvasion
[11]. Peripheral neuroinvasive routes are specifically relevant to
the transmission of human acquired TSE forms such variant
Creutzfeldt-Jakob Disease (vCJD) [12], which poses a potentially
major risk to public health. The question of whether ip
transmissions have a unique genetic basis or one that may be
shared across routes and between agents has to date not been
addressed. A comparative approach to defining genetic common-
ality between traits may therefore be useful for classifying QTLs
according to their empirical relevance to TSE transmissions.
The BXD set of recombinant inbred mice were the genetic cross
chosen for this study. TSE incubation QTLs have not been
explored in this particular background, therefore it is of interest to
determine whether QTLs identified in previous studies could also
be detected here. The BXDs derive from an F2 intercross of
C57BL/6 and DBA/2J progenitors [13]. By definition, recombi-
nant inbred lines are genetically homozygous at each locus and
genotypes for nearly 4000 loci are readily-available. In this case
both progenitor strains are homozygous for the same short-
incubating (s7) prion allele. This effectively eliminates genetic
variation at this locus from the study. The recombinant inbred (RI)
method exploits the fact that the individuals within each line are
genetically identical, hence trait values are based on group means
as opposed to individual measurements. This makes QTL
detection feasible even for traits with low heritability, due to a
compensatory gain in the accuracy of phenotype measurement.
Additionally, the integrative ability of the RI approach can be
exploited in order to produce genetic correlations between traits
which allow both estimations of genetic overlap and heritability of
traits. With this in mind the goals of the work were as follows:
– To determine the total contribution made by genetic variants
of small effect (QTLs) through estimations of trait heritability.
– To estimate possible overlap between the genetic architectures
regulating different transmissions by genetic correlation.
– To identify new QTLs for different treatment conditions,
including the transmission of natural BSE, the de facto
experimental model for vCJD.
– To provide validation of any previously identified QTL
candidates.
Results
The distribution of BXD incubation periods
Raw phenotype data for the BXD lines and the progenitor
strains C57BL/6 and DBA/2J are presented in table 1. An
illustrative representation is shown in Figure 1. Plots of BXD strain
means in Fig. 1 are continuous in nature, confirming the polygenic
nature of TSE incubation times in the BXD genetic background.
In all cases strain means extend outside the range of the
progenitors. Relative differences between strain mean rank for
each trait (table1) allude to trait-dependent genetic involvement.
The lowest overall variances are seen in Me7 ic, (fig. 1b) (129 to
170 days) reflecting the host-adapted nature of this agent. C57
appears to be the less susceptible of the two progenitors overall, as
incubation periods for this strain generally exceed those of DBAs,
(the only exception to this is Me7 ip). Internal reliability was
assessed from BXD incubation period data using the Split-Half
method [13]. A split-half coefficient of 0.7 and above equates to an
s.e.m. of over half (0.55) a standard deviation. The mean Split-
Half coefficient for all traits is 0.90 (all traits). The average
reliability for any single trait is over 0.86 or greater (Table S1).
Heritability Estimations
Heritability in RI mice is determined as one half of the variance
between strain means. Genetic effects in BXDs are predominantly
additive in nature, which permits the calculation of narrow-sense
heritability; ie, the proportion of phenotypic variance ascribable to
additive gene effects (see methods).
The heritabilities shown in table 2 are modest, but provide
evidence that a large component of TSE incubation period may be
influenced by a genetic architecture independent from Prnp.
Heritabilities range from 0.30 (Me7 ic) to 0.60 for Bovine
Spongiform Encephalopathy given ic (BSE ic). This suggests
between 30 to 60% of phenotypic variance may be due to
variation in genes. The upper limit of 0.6 is somewhat surprising
given that direct effects from Prnp (the major genetic locus for the
disease) have been excluded by experimental design. The extent to
which variance between mouse strains (on which these estimates
are based), may be impacted on by factors pertaining to litter or
maternal rearing differences is beyond the scope of this study.
Such interference may occur by way of various epigenetic
processes. These may include the chemical modification of DNA
(genomic imprinting) or interference of messenger RNA. The
reader should refer to [14] for an outline of the theory and [8] for
a direct account of the impact of maternal factors on TSE
incubation time, in an experimental setting. Similar phenomena in
humans may also help to explain discordances in age at onset of up
to 8 years in twins carrying the inherited prion mutation P102L
[15,16]. In this study such effects are assumed to have no net effect
on phenotype.
Broadly speaking, the range of heritabilities shown in table 2
suggests that for some traits the cumulative effect of QTLs on
incubation time may exceed the major locus effect of Prnp. However
neither the existence nor involvement of trans-acting regulators of
Prnp, (which could potentially bias these heritability estimates) can
be ruled out based on our data.
Genetic correlations
Genetic correlations were performed in order to investigate the
possible involvement of QTLs across multiple transmission
models.
The correlations in table 3 estimate the total proportion of host
genetic effects that may be shared by different models. The data
Host Genetic Influence in TSEs
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shared and unique genetic effects.
Some comparisons reach statistical significance. For example,
the correlation between traits exclusively involving either the ip or
the ic route reaches 0.52, p,0.05 (Me7 ic versus BSE ic) and peaks
at 0.67, p,0.05 (for BSE ip versus Me7 ip).
The latter correlation in particular suggests that a partially
conserved genetic infrastructure regulates transmission through
the ip route and seemingly provides evidence of a dynamic effect
across a range of agents, which encompass differences in host-
adaptation.
A strong correlation between BSE ic and BSE ip (r=0.702,
p=0.001) contrasts with the low level of correlation found for Me7
ic and Me7 ip (r=0.38). The case for genuine disparity between
the levels of genetic conservation across routes for natural and
host-adapted isolates would benefit from further replication of
these findings. Curiously, a greater degree of overlap (r=0.6) is
observed between Me7 ic, and BSE ip (p,0.05) than exists
between the two traits involving Me7. This is notable as it suggests
that tight conservation of the supporting architecture can
potentially transcend seemingly random differences in route and
agent. However it is also surprising, given that the relatively high
correlation is found to be unique when the reciprocal comparison
(BSE ic vs Me7 ip) is made (r=0.29).
Unfortunately the study design employed is not well-suited for
discerning what (if anything) is so special about the combination of
Me7 ic and BSE ip. Moreover, due to the absence of a cloned BSE
isolate (such as 301C) from this study, we have been unable to
discern whether the BSE correlation effect is a pre or post species
barrier phenomenon.
Despite the high level of statistical significance achieved the level
of genetic overlap estimated for BSE traits is far from perfect. The
large number of QTLs likely to be operating on this complex trait
dictates that even smaller deviations from a perfect correlation
could be significant from a biological perspective.
Mapping of BXD incubation periods
Summary. Loci meeting nominal significance criteria were
interrogated for superimposed effects from other background loci
(composite interval mapping). Results for the composite interval
mapping (CIM) and simple interval mapping (IM) are given
in table 4 for markers achieving suggestive-level linkage
(Table 4).
The number of QTLs found exceeds theoretical expectation as,
only one false positive is anticipated per genome-wide scan at the
suggestive level [17]. Among the composite mapping results are
three examples where QTLs appear to have effects across traits.
BSE ic; Me7 ic (chromosome 4)
BSE ip; Me7 ic (chromosome 6)
Me7 ip; BSE ip (chromosome 6)
Though the possibility of genetic heterogeneity within QTLs is not
excluded, the data suggest correspondence between these results
and the empirical scheme of genetic overlap outlined by table 3.
Table 4 gives no indication of any delineation between natural and
host-adapted TSE strains. Loci such as D4Mit204 and D6Mit29
are common to both.
Table 1. BXD strain means for prion disease incubation time.
Strain
BSE ic
n=19
BSE ip
n=18
Me7 ic
n=17
Me7 ip
n=16
C57BL/6J 460649 (n=9) 404639 (n=15) 167613 (n=13) 307626 (n=17)
DBA/2J 282613 (n=18) 397651 (n=15) 153611 (n=16) 4486110 (n=12)
BXD1 312692 (n= 9 ) ---
BXD2 411648 (n=14) 374651 (n=15) 345646 (n=10)
BXD6 523641 (n=13) 348676 (n=10) 152614 (n=10) 336618 (n=14)
BXD8 405615 (n=12) 369617 (n=11) 14264( n=8) 267631 (n=12)
BXD9 513652 (n=12) 438631 (n=17) 16568( n=12) 411626 (n=16)
BXD11 504651 (n=16) 443630 (n=15) 15467( n=19) 398665 (n=14)
BXD12 185610 (n=10) 265657 (n=14) 152617 (n=15) 265633 (n=12)
BXD14 478640 (n=10) 412633 (n=14) 15067( n=10) 291647 (n=8)
BXD18 238610 (n=5) 217616 (n=5) 138616 (n=5) -
BXD19 483643 (n=17) 423632 (n=18) 17069( n=14) 343644 (n=19)
BXD21 232645 (n=14) 391624 (n=12) 15965( n=15) 341616 (n=12)
BXD22 417679 (n=12) 39964( n=12) 167614 (n=12) 317624 (n=16)
BXD23 308679 (n=16) 349674 (n=12) 141613 (n=13) 241651 (n=18)
BXD24 517621 (n=9) 410625 (n=16) 152621 (n=16) 319651 (n=15)
BXD25 245670 (n=11) 291678 (n=8) 149611 (n=10) 296627 (n=6)
BXD27 523618 (n=14) 428644 (n=17) 166610 (n=11) 410634 (n=15)
BXD28 2516107 (n=10) 273662 (n=8) 12966( n=9) -
BXD31 406621 (n=14) 286647 (n=12) 157614 (n=10) 256623 (n=14)
BXD32 3916189 (n=9) 434623 (n=17) 148611 (n=14) 3856110 (n=8)
Expt Mean 385653 368638 153611 332643
Incubation period data are given as mean 6 s.d. for each trait. Bovine Spongiform Encephalopathy (BSE), intracranial administration (ic), intraperitoneal administration
(ip).
doi:10.1371/journal.pone.0014186.t001
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also demonstrated in Table 4. Adjustments to LRS score, additive
affect and allelic direction are all noted (all linkage statistics were
improved by the CIM models applied). These refinements are
non-formulaic and depend on the composition of the background
construct, hence the largest LRS score of 46.2 (D6Mit29, Me7 ip)
is actually derived from the lowest IM score shown in this table (ie.
8.1). All loci remained significant after Bonferroni multiple testing
correction was applied to CIM scores.
F2 Analysis
Qualitative comparisons of F2 and BXD phenotype
data. The strongest QTL candidates from the initial BXD
mapping data were selected for confirmatory follow-up in an F2
population. The F2 sample were derived from an identical genetic
background to that of the BXDs. Transmissions of TSE material
were carried out using the same combinations of agent and route
described for BXDs (see methods). Incubation data was
normalised where required (see methods).
Data in Table 5 and the graph in fig. 2 highlight the overall
similarity between BXD and F2 incubation periods. To help
qualify this statement, the calculated Pearson’s r between BXD
and F2 trait means is 0.813 (P=0.049). Additionally, trait means
follow identical rank order to those obtained in BXDs.
The level of correlation found suggests that for TSE incubation
periods, the comparatively lower phenotyping accuracy of F2s can
be overcome with a sufficiently large F2 cohort. Such a strategy
may be attractive for avoiding problems associated with breeding
and maintaining a large RI mouse colony.
Despite the overall similarity between BXD and F2 mouse
panels, individual discrepancies are noted: The panels differ for
Me7 ic and Me7 ip transmissions at the P,0.01 level. BXD traits
values are derived from strain means thus, given the high
reliability scores associated with these values (data not shown), it
is more likely that individual discrepancies are the result of greater
phenotyping error among F2s.
Results of F2 interval mapping. QTLs reaching minimum
suggestive (p=0.63) significance (composite model) are presented.
In all, nine QTLs reach our significance criteria, (table 6). As in
Figure 1. Means and s.e.m of strain incubation periods are given for the four agent/route combinations shown in table 1. Bovine
Spongiform Encephalopathy (BSE), intracranial administration (ic), intraperitoneal administration (ip).
doi:10.1371/journal.pone.0014186.g001
Table 2. Derived estimates of TSE heritability for the BXDs.
Parameter BSE ic BSE ip Me7 ic Me7 ip
Mean VarianceWithinStrain 4697 2068 142 2125
VarianceBetween Strain 13371 4840 123 3033
HeritabilityNarrow sense 0.59 0.54 0.30 0.42
Trait variances and heritability estimations (narrow-sense). Heritabilities were
calculated from incubation time data, having first established the
independence of variance from group size.
doi:10.1371/journal.pone.0014186.t002
Host Genetic Influence in TSEs
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expected false positive rate (one per genomewide scan). Me7 ic is
the only trait for which QTLs are not detected, this reflects the low
phenotypic variance observed in F2s. In the case of F2 interval
mapping the effects of composite mapping on linkage peaks is
much less dramatic than is observed in the BXDs. CIM should
ideally be performed after ensuring that marker coverage is
sufficient to provide an unbiased estimation of background effects.
However this study has only tested those markers chosen to flank
BXD-mapped QTLs.
QTLs on chromosomes 1, 2 and 10 are linked with more than
one trait. These loci demonstrate a corresponding level of allelic
heterogeneity. This, along with the observation of genetic
correlations (table 3), supports the notion that QTLs may have
multiple effects across the different TSE phenotypes explored (ie
QTL pleiotropy). Effects such as those found on chromosome 2
vary between additive and recessive modes. As these character-
istics depend on the surrounding genetic architecture, they are
expected to vary for different transmissions.
The prevailing BXD account of genetic overlap between ic and
ip indicated in tables 3 is substantiated somewhat by QTL data in
Table 4. Table 6 offers further supporting evidence from F2 data.
QTLs on chromosomes 1 and 2 indicate overlapping influences on
both BSE traits. The chromosome 10 locus has a broad effect on ip
transmissions that extends to natural (BSE) and host-adapted
(Me7) isolates. This is contrasted against QTLs on chromosomes 4
and 6, which show specific influences on BSE ic.
Comparison of BXD and F2 mapping data. Our primary
criteria for confirming (ie. replication) is contingent on synchrony
between BXD and F2 loci in terms of both statistical significance
and allelic direction.
Table 7 indicates that confirmation was not possible for 6 out of
7 candidate regions. The exception was chromosome 2, where the
effect found on BSE ic was replicated. Failures are mostly due to an
inadequate significance level being attained.
Loci such as chromosome 4 make for difficult interpretation of
the data, as the locus is clearly implicated by both BXD and F2
BSE ic models, but falls short of our criteria, due to allelic
discrepancies. As discussed above, this too may be a symptom of
including a small and biased pool of markers in the background-
effects model. In order to circumvent the effect of such constraints
to QTL detection, the empirical importance of QTLs effect across
BXD and F2s was also explored by meta-analysis.
Meta-Analysis
Random Effects meta-analysis of BXD and F2
data. Meta-analysis is used in the context of this study to
estimate the overall influence on incubation period of candidate
regions under different experimental treatments. Our methodology,
an implementation of the Random Effects model [18] incorporates
heterogeneity within and between BXD and F2 to derive empirical
estimates of effect size, along with associated confidence intervals
and p values. The random effects model places greater emphasis on
the consistency of effect sizes between studies. Full meta-analysis
resultsareshownintables S2and S3,whereestimationsofthe mean
effect size (Pearson’s r) are provided, along with standard errors and
significance. Data are initially combined between BXDs and F2s
(table S2) before aggregating data of traits to derive empirical
estimates (table S3). One-tailed significance thresholds are derived
from recommended F2 thresholds (two-tailed) for 2 degrees
of freedom [17]. Thresholds are p 8.0610
24 (suggestive) and
p 2.6610
25 (significant).
Meta-Analysis results. The high frequency of loci reaching
suggestive (p=8.0610
24) significance implies relatively low
genetic heterogeneity between effects found for BXDs and F2s.
This further corroborates the phenotypic similarity suggested by
table 5; as consistency of effects is the main basis for linkage under
Table 3. Inter-Trait genetic correlations.
BSE ip Me7ic Me7ip
BSE ic 0.70** 0.52* 0.29
BSE ip 0.60* 0.67*
Me7ic 0.38
Genetic correlations were calculated using BXD incubation data for TSE traits.
*p=0.05,
**p=0.001.
doi:10.1371/journal.pone.0014186.t003
Table 4. Interval mapping results for the BXDs.
QTL Location Condition Marker Position (cM) Probability (LRS) Additive Effect (days) Direction
IM CIM IM CIM IM CIM
Chromosome 4 BSE ic D4Mit204 61.9 16.9* 36.4*** 86.5 59.3 C57 C57
Chromosome 4 Me7 ic D4Mit204 61.9 11.4* 28.2*** 7.5 5.7 C57 DBA
Chromosome 6 BSE ip D6Mit29 36.5 15.3* 24.7** 51.1 51.5 DBA DBA
Chromosome 6 Me7 ic D6Mit67 41.5 13.2* 41.1*** 8.0 12.8 DBA DBA
Chromosome 6 Me7 ip D6Mit29 36.5 8.1* 46.2*** 39.2 45.7 DBA DBA
Chromosome 10 BSE ic S10Gnf020.445 14.8 18.1* 46.1*** 97.9 78.2 C57 C57
Chromosome 11 BSE ip D11Mit179 52.0 12.8* 23.8** 49.5 32.4 DBA DBA
Chromosome 18 Me7 ip D18Mit19 4.0 15.2* 43.8*** 44.7 52.3 DBA DBA
Simple and composite mapping data for TSE incubation times. Only the peak marker within each QTL region is shown in each case. Asterisks denote genome-wide
significance, thresholds for which were calculated by 10,000 permutations of trait data:
*Suggestive,
**Significant;
***Highly significant thresholds correspond to the 37
th,9 5
th and 99.9
th percentiles, respectively. Allele direction indicates the allele mediating the increase in incubation
time.
doi:10.1371/journal.pone.0014186.t004
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thresholds are summarised in table 8.
The application of a random effects meta-analytical method to
BXD/F2 transmission data has resulted in ten traits meeting
minimum criteria for linkage. Of these, three reach genomewide
significance (ie. with P,2.6610
25). These are:
Me7 ic on chromosome 4: r 0.3060.06, p 4.0610
28
BSE ip on chromosome 11: r 0.2360.05, p 1.0610
25
BSE ip on chromosome 18: r 0.2260.05, p 1.9610
25
The strongest overall effect is found at chromosome 4 (r=0.30).
This locus also achieves the highest overall significance, at 10
28.
The ten hits are distributed across six intervals and apply to three
out of four traits analysed (table S2). Not represented among them
is Me7 ip. Paradoxically, the largest number of hits (four) is found
for Me7 ic, a trait from which the lowest phenotypic variations
were derived. The possibility exists that statistical significances
associated with the trait Me7 ic merely reflect this low variation
across BXDs and F2s given the emphasis of random effects
methods on effect homogeneity. However, we fail to find evidence
that the group of uncombined effect sizes found for this trait differs
significantly from other traits analysed, Ptwo-tailed=0.927 (T-test).
The chromosome 11 QTL demonstrates general influence
on TSE incubation periods. The rate of linkage at any level of
significance diminishes as traits are combined (table S3), thus we
find evidence of just one generally-acting QTL; the linkage region
on chromosome 11. Tabulated data for this region are given in
table 9. The chromosome 11 locus is significant overall
(P=9610
210). Additional significant effects are observed for ic
and Me7 experiments (P=2610
27 and 7610
27 respectively).
Effects for BSE reach suggestive (P=1610
24). ip transmissions
show only a trend towards significance (P=0.002). This is due to
the larger standard errors associated with these estimated effects.
All are consistent in direction, with reductions in disease
progression (which corresponds with lengthening incubation
time) mediated by DBA alleles.
The r
2 (table 9) gives estimations about the proportional additive
variances from the locus. We estimate the overall contribution to
phenotypic variance to be about 3%.
Discussion
A long line of previous work has already established non Prnp-
linked genetic modifiers as important determinants of incubation
time [2,5,7,8]. As it is customary that the initial scientific rationale
for such work is provided by analyses of heritability, it is slightly
ironic that the estimation of heritability for human prion
phenotypes has only very recently been possible [19]. One factor
precluding heritability analyses of vCJD, a future potential public
health risk, is its low recurrence rate among nuclear families; there
has been just one case of vCJD recurring in a family (Source:
European Centre for Disease Prevention).
The heritability of age at onset and death for the human inherited
TSE form was recently determined to be 0.55 (95% CI 0.35–0.75)
[19]. This value is comparable to our own estimates which derive
from a related phenotype and are the first to be reported for an
acquired TSE (h
2
narrow sense range =0.3 to 0.6). As in [19], our
estimates exclude direct effects from Prnp and suggest a
cumulatively modest contribution of non-Prnp effects. We
demonstrate that they may nevertheless outweigh those of the
only known major locus, in response to varying the parameters
explored by this study.
Our QTL data, only partially justifies our findings in relation to
heritability, thus we acknowledge and draw further attention to the
many possible sources of bias on which such estimates may rely
[14], [8]. Additionally further biases may result due to the
relatively small proportion of the currently available BXD strains
sampled in the study, irrespective of any phenotypic similarity
observed between BXDs and F2s across traits (Pearson’s r 0.813,
p=0.049). In this instance, the use of the expanded BXD set now
Figure 2. Boxplot comparison of BXD strain and F2 incubation
period data by experiment. Black horizontal lines within the
coloured bars give the median in each experiment. Lower and upper
boundaries of blue bar represent 25
th and 75
th percentiles, respectively.
Lower and upper tails demarcate largest and smallest values within 95%
confidence interval. Me7 ic and Me7 ip transmissions produce
significantly different incubation times between BXDs and F2s.
doi:10.1371/journal.pone.0014186.g002
Table 5. Comparison of means for BXD and F2 incubation periods.
Experiment Mean BXD Incubation period (Days±s.e.m) Mean F2 Incubation period (Days±s.e.m)
BSE ic 386626.5 34563.5
BSE ip 364616.4 33763.3
Me7 ic* 15262.7 12962
Me7 ip* 326613.8 29266
Phenotypic comparisons of BXD and F2 means. This data is based on data presented in table 1, although in this instance the progenitor strains are omitted from
calculated values to ensure an unbiased comparison of mean phenotype values. Data for the progenitor strains.
*BXD and F2 means differ significantly at the P,0.01 level (T-test).
doi:10.1371/journal.pone.0014186.t005
Host Genetic Influence in TSEs
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Location
(Chr) Transmission
Mapping
model
F2 LRS
Statistics
95% Support
Interval (1-LOD)
F2 Additive Effect
(Standardised)
F2 Dominance effect
(Standardised)
1 BSE ic Simple 10.8* 0.24 20.11
Composite 12.9* 37.8–61.1 cM 0.27 20.15
BSE ip Simple 11.7* 0.15 0.71
Composite 10.3* .37.8 cM 0.28 0.38
Me7 ip Simple 13.1** 20.44 0.46
Composite 9.9* 21.7–38.1 cM 20.43 0.37
2 BSE ic Simple 5.6 20.23 20.16
Composite 7.5* 1.0–25.3 cM 20.27 20.11
BSE ip Simple 10.0* 20.31 0.28
Composite 9.9* 20.0–54.0 cM 20.29 0.32
10 Me7 ip Simple 8.3* 20.33 20.34
Composite 7.6* 17.0–66.0 cM 20.47 20.91
BSE ip Simple 7.9* 0.30 20.70
Composite 7.0* .10.0 cM 0.30 20.66
4 BSE ic Simple 13.4* 20.08 20.39
Composite 10.5* 65.6–68.7 cM 20.07 20.37
6 BSE ic Simple 11.6* 0.06 0.52
Composite 7.6* 46.3–51.9 cM 0.09 0.48
Summary of QTLs identified by composite mapping F2 incubation data.
*=Suggestive.
**=Significant genome-wide probability. Additive and dominance effect were calculated under an unconstrained genetic model and standardised by dividing by the
standard deviation of the corresponding raw data. Minus values refer to the DBA direction, positive values refer to C57BL.
doi:10.1371/journal.pone.0014186.t006
Table 7. BXD and F2 mapping data.
Location of Interval Trait
Interval mapping
model
Peak
BXD LRS
F2 LRS
Statistics
Additive effect
direction bxd
(After CIM)
Additive effect
direction F2
(After CIM)
Chromosome 2 (1.0–27.3 cM) BSE ic Simple 5.6 2.6 DBA/2J DBA/2J
Composite 7.5* 20.1*
Chromosome 4 (53.6–81.7 cM) BSE ic Simple 16.9* 13.4* C57BL/6 DBA/2J
Composite 36.4*** 10.5*
Chromosome 4 (53.6–81.7 cM) Me7 ic Simple 11.4* 5.5 DBA/2J
{ C57BL/6
Composite 28.2*** 2.4
Chromosome 6 (15.3–45.5 cM) Me7 ic Simple 13.2* 2.6 DBA/2J C57BL/6
Composite 41.1*** 3.5
Chromosome 10 (2.0–29.0 cM) BSE ic Simple 18.1* 1.8 C57BL/6 C57BL/6
Composite 46.1*** 3.3
Chromosome 11 (40–65.0 cM) BSE ip Simple 12.8* 5.4 DBA/2J DBA/2J
Composite 23.8** 5.8
Chromosome 18 (4.0–17.0 cM) Me7 ip Simple 15.2** 4.5 DBA/2J C57BL/6
Composite 43.8*** 2.8
BXD and F2 QTL mapping data are shown. Loci linked to trait above the suggestive threshold (composite mapping) in BXDs are presented with the corresponding LRS
score reached in F2s (Composite interval mapping).
*Suggestive level,
**Significant level,
***Highly significant.
doi:10.1371/journal.pone.0014186.t007
Host Genetic Influence in TSEs
PLoS ONE | www.plosone.org 7 December 2010 | Volume 5 | Issue 12 | e14186available was not possible, but may well have resolved such
curiosities as a recurrent but unconfirmed locus on chromosome
10 for BSE ic (BXD), Me7 ip (F2), and BSE ip (F2). Such patterns
may not occur randomly and may actually reflect additional
complexity at these loci. Evidence that the distribution of BXD
and F2 QTLs in our data is non-random derives from the fact
that:
(i) A combination of stringently employed mapping and meta-
analytical methodologies have yielded many pre-existing
QTLs known to be involved in controlling prion incubation
times.
(ii) There are a high number of F2 QTLs in relation to the much
smaller hypothesis region tested (9 F2 QTLs were identified
within the 27 marker loci tested, whereas 12 BXD QTLs
were identified across 3795 tested marker loci). The F2
number is significantly higher than a priori expectations based
on extrapolated BXD data (PYates corrected x2,,0.0001) and
argues that the methodological procedures in the BXD
analysis offer sufficient protection against Type 1 error in this
study. This implies enrichment for genuine QTLs in BXD
and F2 data as well as further complexity in the mechanism
underlying these QTLs. That previously reported QTLs
were detected by this study goes some way to reaffirming the
validity of a novel suggestive (p,8610
24) locus on
chromosome 1 (35–62 cM) and a significant (p,2.6610
25)
locus on chromosome 18 (4–17 cM).
F2 mapping was, by itself, able to reproduce a locus on
chromosome 2 specific to BSE ic that reached the genomewide
threshold for suggestive significance (p=0.63). That this locus did
not survive the subsequent random effects meta-analysis procedure
merely emphasises the heterogeneity between the BXD and F2
estimates and does not contradict the initial evidence suggesting
linkage at this region. The chromosome 2 QTL lies approximately
50 centiMorgans (cM) upstream of Prnp (located at 75 cM).
Independence of the chromosome 2 locus from Prnp is assumed.
Among the loci identified for ic transmissions are a number of
familiar linkage regions, (corresponding to regions of chromo-
somes 2, 4, and 11) previously linked to this route [5,7].
We are the first study to attempt to quantify the genetic basis of
aetiological overlap governing different routes and agents. Table 3
highlights the potential for strong overlap effects, even when traits
differ simultaneously by host adaptation, route and agent. The
caveat is that strong effects of route and agent on genetic influence,
suggest that QTLs identified in one study cannot necessarily be
extrapolated to transmission models based on different combina-
tions of agent and route. Thus, while it may be too tempting to
resist extrapolating previously reported data to the oral route (a
route more relevant to the transmission vCJD) our data suggest
that doing so may blur the little that we understand of the genetic
processes regulating the transmission of vCJD and the potential
risk to public health that they may represent. This is because even
the strongest correlating traits in our study do not share more than
70% of genetic influences in common, while our lowest estimates
suggest that the dissimilarity between transmissions can mean just
50% overlap or less, even between transmissions using a common
administration route (table 3).
The overall implication is that any lingering uncertainty about
the identity of risk variants in vCJD may be best tackled using
mapping strategies that specifically target the more relevant oral
route. Reassuringly, table 3 suggests some portion of genetic
influence may be common to all traits. The emphatic nature of
the meta-analysis result and other prior linkage evidence makes
t h ec h r o m o s o m e1 1l o c u so n ep r i m ec a n d i d a t ef o rm e d i a t i n g
such a role. Meta-analysis also highlights a number of other
significant candidate regions, which are summarised in table 8.
Trait-specific QTL effects of varying significance were found on
chromosomes 1, 2, 4, 6 and 18, after the merging of BXD and F2
data.
Our data represent the third independent report of a distinct
TSE locus on chromosome 2 (fig. 3a). The linkage region overlaps
with previous QTLs identified in [8] and [7]. Other QTLs located
at the distal end of chromosome 2 have been identified by Lloyd
et al [7,9]. It is not clear to what extent these may be specific to the
CAST/Ei x NZW/OlaHsd background in which they occurred.
Interestingly one of the regions of Lloyd et al spans loci of both the
prion protein (Prnp) and that of its paralogue Doppel (Prnd),
although sequence symmetry between progenitor strains at this
locus rules out effects from within either gene. We are the third
group to independently report the existence of QTLs for prion
disease on chromosome 11. Previous studies have already
established this chromosome as a good linkage candidate.
Crucially however, our meta-analysis data attaches empirical
significance to this locus. This suggests wider involvement across a
variety of other transmission types not characterised previously.
Candidate-based explorations of the region have so far failed to
reveal the origins of such effects [20].
Table 8. Summary of important meta-analysis findings.
QTL Locus Trait Effect size, r
Genome-wide
Significance
Chromosome 1 Me7 ic 0.2060.06 Suggestive
BSE ip 0.2860.07 Suggestive
Chromosome 2 Me7 ic 20.2260.06 Suggestive
Chromosome 4 Me7 ic 20.30 60.06 Significant
BSE ic 20.1960.05 Suggestive
Chromosome 6 BSE ic 0.1560.04 Suggestive
Chromosome 11 Me7 ic 20.1960.06 Suggestive
BSE ip 20.2360.05 Significant
BSE ic 20.1560.04 Suggestive
Chromosome 18 BSE ip 20.2260.05 Significant
Loci of varying significance identified by Random Effects meta-analysis are
given with associated effect sizes. Signs indicate directionality of the allelic
effect; ‘2‘ corresponds to DBA and ‘+’ corresponds to C57 alleles.
doi:10.1371/journal.pone.0014186.t008
Table 9. Breakdown of meta-analysis effects found in
chromosome 11 QTL region.
Agent Combined r± s.e.m r
2 Direction P Value
BSE 20.1960.05 0.04 DBA2/J 1610
24*
Me7 20.1860.04 0.03 DBA2/J 7610
27* *
ip route 20.1860.06 0.03 DBA2/J 2610
23
ic route 20.1860.03 0.03 DBA2/J 2610
27* *
All Expts 20.1860.03 0.03 DBA2/J 9610
210**
Summary of combined effects at Chromosome 11 locus. Varying s.e.m sizes
underlie the large differences in significance.
*Suggestive;
**Significance.
doi:10.1371/journal.pone.0014186.t009
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factors to those found in a previous investigation of the ic route [7]
confirming the veracity of these loci. This result is perhaps not
surprising given that each study uses the same genetic cross
(NZW/Hsd and Cast/Ei) and only the TSE strain used (both host-
adapted) varies. Moreno et al [10] and Manolakou et al [8]
employ prion agents at different stages of host-adaptation. This
may account for individual discrepancies between these results (in
addition to methodological and environmental/epigenetic consid-
erations) although, common regions on chromosomes 4 and 8
indicate a broader similarity between their findings.
Previous studies show a bias towards C57-derived genetic
backgrounds. Of the QTLs shown in fig. 3b we see that regions on
chromosomes 2, 6 and 11 have the most general influence across
varied genetic backgrounds. The chromosome 11 has already been
mapped in two non C57-derived backgrounds, while loci on
chromosomes 2 and 6 have been identified in the NZW/Hsd and
Cast/Ei genetic cross.
A recent GWA study of human TSEs draws attention to novel
common variants associated with clinical phenotypes, implicating
genes such as STMN2 and RARB. In addition, previously unchar-
acterised variants have also been discovered within PRNP [6]. The
study identified two loci of genome-wide importance, one in strong LD
with the major locus at codon 129 and another found in the intergenic
region between RARB and THRB. The other genome-wide significant
finding in this study highlighted a locus for orally acquired TSEs (vCJD
and Kuru), using meta-analysis. Underlying genetic heterogeneity
found between TSE categories in this study mirrors our own findings.
We assume this to reflect that factors such as agent, dose and route also
have an important role in aetiological determinism and its corre-
sponding genetic framework.
The low recurrence rate of familial vCJD precludes studies of
human linkage, in which rare disease loci may be detected by
virtue of their increased occurrence among affected relatives. This
and the low global incidence of vCJD, means increasingly-
available next-generation sequencing methods cannot yet be fully
exploited to define the possible contribution of rare variants to the
TSEs. Recent progress made, across psychiatry in particular, has
helped to demonstrate the pathogenic potential of this variant class
[21]. Meanwhile, the continued application of linkage studies to
murine proxies must continue in order to provide further cues for
fine-mapping and positional cloning work. Gene targets identified
Figure 3. Summary of QTL intervals affecting TSE transmission by study (3a) and by genetic background (3b). Only chromosomes with
multiple QTL assignments are presented. All intervals with the exception of Lloyd et al are calculated in the absence of background modifiers.
Manolakou intervals are estimated using XYExtract V2.5 (2004) of Cleiton and Silva.
doi:10.1371/journal.pone.0014186.g003
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exploiting synteny between murine and human biological systems.
QTL mapping in Heterogeneous Stock mice offers superior
resolution to the RI approach and use of this genetic resource has
the potential to expedite the search for QTLs by reducing the size
of candidate regions to relatively few genes. Such approaches have
been applied to great effect and have heralded the first wave of
gene candidates and confirmed trait loci [22,23] to derive from
murine QTL mapping of the TSEs.
Conclusion
Our findings concur with previous reports linking QTLs on
chromosomes 2, 4, 6 with TSE incubation time. We also report a
novelQTLonchromosome 18.Additionallyourresultsenable usto
extrapolate from a previous linkage region on chromosome 11
linked with ic transmissions, to a general effect spanning across ic/ip
routes and natural/host adapted prion agents. The generality of this
locus may make it a prime candidate for involvement in the general
pathogenesis of TSEs, including vCJD. Our demonstration of the
substantial selectively with which host genetics may act across
different transmission models suggests that not all QTLs identified
using the historically favoured ic model will feature as strongly for
orally acquired TSEs. The enduring aetiological relevance of this
route to vCJD contrasts with the apparent decline in the number of
cases resulting from blood transfusions [24,25]. Thus a paradigm
shift may be warranted to aid the detection of biological effects
specific to vCJD. Such reasoning dictates that oral TSE transmis-
sions should be the next priority for mapping studies of this type.
Table 10. Summary of TSE linkage findings to date.
Study Genetic Cross Agent Route Interval Maximum effect size (r)
Susceptible Resistant
Stephenson 2001 SJL/J Cast/Ei
105 Days 172 Days Chandler Scrapie ic Chr10: 60 cM -
Chr11: 37–57 cM 0.41
Chr7: 72.4 cM -
Chr9: 17–26 cM -
Chr18: 24 cM -
Chr19: 16–24 cM -
Lloyd et al 2001 NZW/OlaHsd Cast/Ei
108 Days 188 Days Chandler Scrapie ic Chr2: 17–37 cM 0.27
Chr11: 1–65 cM 0.50
Chr12: 4–34 cM 0.26
Chr6: 17.5 cM 0.13
Chr7: 28.4 cM 0.14
Manolakou et al 2001 RIII C57BL
442 Days 540 Days BSE ic Chr2: 6.4–29 cM 0.23
Chr8: 22–35 cM 0.23
Chr4: 19.9–33.6 cM 0.23
Chr15: 17.2–53.4 cM 0.23
Lloyd et al 2002 NZW/OlaHsd Cast/Ei
133 Days 181 Days 3rd Passage BSE ic Chr2: 54–94 cM 0.53
Chr11: 32–62 cM 0.39
Moreno et al 2003 RIII C57BL
161 Days 167 Days Me7 ic Chr4: 34–64 cM 0.22
Chr5: 51–72 cM 0.36
Chr6: 25–67 cM 0.30
Chr7: 2–18 cM 0.22
Chr8: 22–64 cM 0.26
Chr17: 7–21 cM 0.22
Chr17: 36–46 cM 0.26
Iyegbe et al 2009 DBA/2J C57BL/6
278 Days 454 Days BSE ic Chr2:1–25.3 cM 0.11
a
Iyegbe et al 2009 DBA/2J C57BL/6
351 Days 319 Days All All Chr11:40–65 cM 0.17
a
Summary of all TSE QTLs identified to date. Effect sizes are calculated from percentage variances reported in published data. These are unconstrained estimates which
exclude the effects of background markers.
aDerived from BXD and F2 data combined by meta-analysis (random effects) methods.
doi:10.1371/journal.pone.0014186.t010
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Ethics statement
Animals were maintained with a 12 hour day/night cycle in a
specific pathogen-free (SPF) facility by trained, qualified animal
technicians. General husbandry was carried out on a daily basis.
Animals had free access to food and water throughout the
experiment. The experimental design was vetted and approved by
the Home Office (project licence number: PPL 70/4351).
Transmissions were conducted in a category 3 biohazard
containment unit using either halothane/oxygen or isoflourane/
oxygen for anaesthesia purposes.
Animals were checked daily for neurological symptoms by a
research staff member trained and approved in animal handling
by the Animal Procedures department of the Home Office. Onset
of disease was taken as the onset of three or more concurrent
neurological signs. Mice were sacrificed at a defined endpoint of
two weeks post diagnosis.
Mice used in the study
The BXD mouse set is derived from an F2 intercross between
C57BL/6 and DBA/2J progenitors. 26 successive generations of
brother-sister mating result in the generation of inbred mouselines
that are homozygous at virtually every locus [13]. BXD
recombinant inbred mouse strains and their progenitors C57BL/
6J and DBA2/J were imported from Jackson Laboratories (Bar
Harbour, Maine, USA) and maintained by brother-sister mating.
All mice were housed under specific pathogen-free conditions for
the duration of the experiment. BXDs were routinely tested for
homozygosity during the course the study to maintain the integrity
of each line. One strain (33ty) was excluded on this basis. F2 mice
were generated in-house from an F1 cross. Mice used were
uniquely identifiable using subcutaneous transponder tags (AVID,
UK).
Group sizes
Group sizes for the study are given in table 11. Commercial
availability of BXD lines determined the number and pattern of
strain usage in each experiment. This was mitigated by the survival
and proliferation characteristics of each line after importation to
UK. BSE ic transmissions were heavily prioritised in the F2 study.
This was to ensure sufficient numbers to allow meaningful
comparisons with previous studies.
Adult female mice aged 10–12 weeks old were used. Female
mice were used in preference to males as, although group-housing
by sex is the only feasible way to maintain a cohort of this size,
severe injury and death in males caused by fighting was very
frequently observed in a smaller pilot study. The small standard
deviations associated with incubation time in BXD mice (see
results) suggested a negligible effect of hormonal status.
Age-matched controls were given uninfected brain homogenate
at the same dosage and volume as those administered infectious
material. Group sizes for controls ranged between 5 and 10. There
was no effect of inoculation batch on incubation time for any
experiment.
TSE agents used
BSE affected bovine brain was provided by Central Veterinary
Laboratories, Weybridge, UK. Cloned ME7 mouse-adapted
scrapie was obtained from BBSRC, UK. Me7 was propagated
by passage in C57 animals inoculated ic. Brains were harvested at
terminal stages of disease.
Transmissions
General procedure. Transmissions were conducted in a
category 3 biohazard containment unit. Anaesthesia was carried
out using halothane/oxygen. 30 ml of 1% w/v infective brain
homogenate was injected into the right parietal lobe for all intra-
cerebral (ic) inoculations. Intra-peritoneal (ip) inoculations used
either 100 ml of 10% w/v BSE or 30 ml of 0.1% w/v Me7.
Injections were given in the intraperitoneal cavity of the
abdominal region. Experimental controls for ic and ip
transmissions were inoculated under the same experimental
conditions using identical quantities of uninfected mouse brain
material.
Dosing strategy. The dosage scheme adopted by this study
follows the observation that use of low dose inoculum is associated
with increased variability of incubation time [26]. This suggests
that it is not feasible to apply the same standard dose to different
routes, as this could create bias in the distribution of BXD
incubation times. The extent of the bias would be determined by
the variable transmission efficiency associated with individual
routes. The incubation period data derived from such an approach
would actually make traits less suited for evaluations of potential
overlap (ie. genetic correlations).
In the worst case scenario, the variability arising from ‘under-
dosing’ of routes could mean only a proportion of mice ultimately
go on to develop clinical disease within average lifetime. To
circumvent this possibility, titration studies were performed during
the pilot phase of the study. These were used to establish the
minimum dose required to ensure 100% transition from the pre-
clinical to clinical disease status within a normal lifespan. These
dosages were subsequently adopted for the main study. The
advantages of this solution are two-fold:
i) constraining of the total phenotypic variance in this way
reduces measurement error. This is because data are derived
from measurable endpoints, whereas if incubation periods
were to exceed natural lifespan of the host it would only be
possible to define the clinical endpoint by extrapolation of the
observed data.
ii) the comparability of the resulting incubation period data is
increased for genetic correlation purposes, as dosages for each
trait are calibrated against a single ‘hit-rate’ target of 100%.
Diagnosis. Animals were checked daily for neurological
signs. Onset of disease was taken as the appearance of three or
more concurrent neurological signs. Symptoms included dysmetria
(as assessed by cage-top tests), tremor, wobbly gait and foot
clasping [1]. Head tilting, vacant staring and abnormal
hyperactivity were other frequent indicators of early end-stage.
Mice were sacrificed at a defined endpoint of two weeks post
diagnosis. The experiment was terminated sooner for animals
whose rate of physical decline warranted this. Incubation time was
Table 11. Breakdown of group sizes used.
Experiment BXD Strains F2 mice
BSE ic 19 480
BSE ip 18 212
Me7 ic 17 135
Me7 ip 16 123
Group sizes used in BXD and F2 studies.
doi:10.1371/journal.pone.0014186.t011
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establishment of three disease symptoms. Apart from intercurrent
illnesss (accountable for death in 7% of cases), all inoculated
animals became ill with prion disease.
Neuropathology. All neuropathology was performed by the
department of Neuropathology at the Institute of Psychiatry,
London, UK. Brains of terminally ill animals were removed, fixed
in formaldehyde/saline and processed for either haematoxylin and
eosin staining or immuno-histochemical staining of PrP deposits
using SP40 anti-PrP polyclonal antibody. Confirmation of disease
in each of the experimental groups has been achieved by either
establishing the existence of PrP-positive amyloid deposits [27]
and/or the appearance of neuronal vacuolation in the medulla as
in [28]. PrP
sc positivity in the medulla was limited to 40% of brain
tissues examined. However these animals were recorded as being
infected, on the basis of the following:
(i) Neuronal vacuolation was observed in the medulla of all
affected brains.
(ii) No evidence was found of any inflammatory response or
other superimposed disease effects.
(iii) Neither injected nor non-injected age-matched controls
displayed TSE symptoms (Controls were allowed to go
beyond two standard deviations from the tabulated BXD
incubation means).
(iv) Scoring was performed blind with respect to affective status
(ie. case or control). TSE-related vacuoles were found only
in the brains of prion-inoculated mice
(v) There is no evidence in our data to suggest that the plaque-
negative animals form a distinct subgroup in terms of
incubation periods (Mann-Whitney U test).
Statistical analyses
General statistical analyses. Basic statistical analyses were
carried out using SPSS v13 (LEAD technologies) and MiniTab
(MiniTab Inc.).
Reliability of BXD data. Internal consistency (or reliability)
of the data was estimated in SPSS using the Split-Half method
[29]. Estimates were obtained by randomly dividing data for
individual strains into two (odds and evens). A split-half coefficient
was obtained from the correlation between the two halves. The
result (typically over-conservative) is corrected to give a full test
score using the Spearman-Brown prophecy formula (SPSS).
Genetic calculations. Genetic correlation was investigated
in the BXD study by Pearson’s correlation of BXD means across
traits. This has allowed exploration of genetic overlap between the
traits. Calculation of heritability estimated the contribution of
genetics overall to each transmission phenotype. Being that
members of each BXD line are genetically identical, any
variation within each line is ascribed to environmental variance,
whereas variance between strains is genetic. One half of the
variance of means between the BXD lines estimates additive
genetic variance (VA) while, the mean within-strain variance
estimates mean environmental variance (VE). Thus, an estimate of
narrow-sense heritability (h
2
n) may be obtained using the formula
[30]:
h
2
n~
VA
VEzVA
ð1Þ
Regression analysis and Interval mapping. QTL analysis
was performed by initial linear regression of BXD phenotype data
across genotypes at each marker. Simple interval mapping was
subsequently implemented using Mapmanager QTX v20b [31]
using trait variances to weight BXD strain means.
For F2s interval mapping was performed using consensus map
distances from the Mouse Genome database (www.informatics.jax.
org). An unconstrained regression model was used with the
strength of linkage in each region expressed as a likelihood ratio
statistic.
Significance thresholds for the genome scan. Geno-
mewide significance thresholds are based on 10,000
permutations of the data (Mapmanager QTX). In order to
remove any bias from the computed statistics C57BL/6 and
DBA2/J data were excluded from permutation and from simple
and composite mapping. Two levels of significance are used to
assess the strength of linkage or association in genomewide studies:
The suggestive threshold represents the approximate value of the
Likelihood Ratio Statistic (LRS) that would be expected to yield on
average one false positive per genome scan [17]. In the QTL
analysis of BXD mice this corresponds to a genomewide p-value of
0.63 [31]. Though this threshold is very permissive, it is extremely
useful for highlighting loci worthy of follow-up. In this case loci
reaching suggestive significance will be followed-up in a confir-
matory screen that utilises F2 mice. Meanwhile, the significant
threshold represents the approximate LRS value that would be
expected to yield on average one false positive every twenty
genome scans [17]. Here this corresponds to a genomewide p-
value of 0.05 [31].
Composite interval mapping. The WebQTL interface,
located at www.genenetwork.org, was used to perform initial
interval mapping. This was followed up with a comprehensive
analysis of genome-wide linkage using Mapmanager QTXvb20
[31]. Loci meeting nominal significance criteria were interrogated
for superimposed effects of other background loci (composite
mapping). This was done using multiple regression to establish a
panel of background markers under the assumption that
constitutively these markers do not act epistatically. A forward
step-wise strategy was employed in which the strongest linked
markers were added to the background locus model if they
improved the fit at the P,0.05 level. QTL Cartographer v2.5
(North Carolina State University) confirmed the location of all F2
QTLs identified in Mapmanager and found a high level of
agreement between the observed effects (Spearman’s rho =0.71,
P=0.0001).
Genotyping
Marker selection. .An advantage of the RI method is that
the BXDs are already genetically characterised at over 4000
markers, thus BXD mice require no additional genotyping. For
each BXD region nominated for F2 follow-up, markers were
chosen on the basis of location and heterozygosity between C57
and DBA progenitors from the Mouse Genome Database (http://
www.informatics.jax.org) and the Roche database (http://
mousesnp.roche.com). Markers 10 cM either side of each
candidate peak were chosen [32]. The phenotypic distribution
across the genotypes generally followed the expected 1:2:1 ratio
with the exception of D6Mit384 this marker was therefore
excluded from the BSE ip analysis.
Polymerase Chain Reaction. DNA was extracted from
1 cm F2 tail samples prior to transmissions using a commercially
available kit (Qiagen, cat. No. 69506). 10 ng of DNA (in 5 mlo f
double-distilled water) was used as the template in 20 ml
polymerase chain reactions (PCR). Reactions were carried out in
96-well plates using a PTC-200 thermocycler (GRI, UK). The
reaction mix consisted of dNTPs (200 mM), AmpliTaq-Gold and
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forward/reverse primers (1 picoMolar of each). The 59 end of
each forward primer was fluorescently labelled with either Hex,
Fam (MWG Biotech, Germany) or Ned (Applied Biosystems, UK).
All reverse primers were obtained from MWG Biotech.
The reaction sequence was as follows: 94uC for 5 minutes; 94uC
for 30 seconds, 15 seconds at annealing temperature, 72uC for 30
seconds for 35–40 cycles; 72uC for 5 minutes.
Marker Discrimination. PCR products were run in
multiplex on a 3100 genetic analyser (Applied Biosystems).
Pooled sample were heat denatured in formamide (HiDi,
Applied Biosystems) for 2 minutes at 94uC and subsequently
snap frozen before being run using a 5 second injection time using
a Rox GS-500 size standard (Applied Biosystems). Resolution of
individual products within the multiplex required a minimum
fluorescence signal of not less than 1000 units per PCR product.
The software ‘Genotyper’ (Applied Biosystems) was used to
analyse and genotype the output data.
Meta-analytical methods
Pre-processing of data. Implementation of Random-Effects
meta-analysis formulae was performed in Microsoft Excel
spreadsheets. The effect size r was derived from the estimated
variances calculated in Mapmanager, (valid since this equates to
r
2). Conversion of r to Fisher’s Z (Zr) is recommended [18,33].
The conversion is based on the following formula:
Zr~
1
2
loge
1zr
1{r
  
ð2Þ
In practise this is done using a standard conversion table.
Differences in the sign associated with a given effect (ie, allelic
direction) are accounted for by assigning positive and negative Zr
signs for C57BL/6 and DBA/2J alleles respectively.
Calculation of heterogeneity. Calculation of heterogeneity
was performed using equations appropriate to the number of
studies being combined [34]. Equation (3).
Q~
X
n{3 ðÞ Zr{Zr
   2 ð3Þ
was used for 3 or more studies [18,34]. Q, the weighted sum of
squared errors, has a x2distribution with K-1 degrees of freedom
when k equals the number of studies being compared. Equation (4)
was used for comparisons of 2 studies (adapted from [34]).
Z~
Zr1{Zr2 ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
1
n{3
z
1
n{3
r ð4Þ
Equation 4 returns a standard normal deviation (Z) score for
which the corresponding p value was obtained using a standard
conversion table. This statistic was converted to a x2 statistic with 1
degree of freedom, equivalent to Q in equation (3).
Between-study variance. The between-study variance is an
expression of the overall variance between two or more studies,
taking into account all of its possible sources. [16] provides
equations for estimating the between-study variance (t2) that
incorporate the heterogeneity calculated using equations (3) or (4),
and a constant (c):
t2~
QK {1 ðÞ
c
ð5Þ
This was applied in stages so that heterogeneity was first
calculated between BXD and F2s for the same trait, and then
between traits making up each measure. For example, the measure
‘BSE’ comprises BSE ic and BSE ip). When BXD and F2 data are
initially combined, the constant c is calculated using fixed-effect
weights as this step occurs before random effects weights are
calculated.
c~
X
w{
P
w2
P
w
where w~n{3 ðÞ ð 6Þ
For subsequent combining between transmissions (for example,
Me7 ic and Me7 ip) random effect weights (w*) are used:
w ~
1
n{3
zt2
   {1
ð7Þ
t2is accumulated over each combination step.
The weighted mean effect and its standard error. Both
between-study variance (t2) and the within-study variance (n-3) are
combined to produce a weighting coefficient (equation 7) for
eachZr. Implementation of the weighting gives the weighted mean
effect size, (equation 8) in terms ofZr. This equation is used to
combine this metric across BXD and F2 experiments and between
measures:
Zr~
P
wZr
P
w
ð8Þ
Actual weighted means are derived after transformation back to
r fromZr. The sampling variance of the average effect size is the
reciprocal of the sum of weights [18] therefore the standard error
of the average effect size is the square root of the sampling
variance, hence:
SEZr~
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
1
P
w
s
ð9Þ
It is recommended that the Z-score of the weighted mean effect
is obtained by dividing the mean effect size by its standard error
[18]. This enables the probability associated with r to be calculated
via a standard Z to P conversion table.
Supporting Information
Table S1 Reliability of BXD incubation data per trait.
Summary of ‘Split-Half’ reliability estimates. BXD averages are
calculated by strain across experiments. Experimental averages are
calculated by condition across strains. *These reliability estimates
are constrained by low phenotypic variance within the group.
Found at: doi:10.1371/journal.pone.0014186.s001 (0.07 MB
DOC)
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meta-analysis procedure. Weighted mean r’s for combined BXD
and F2s data, r6 s.e.m (see methods). Conversion of Zr to r is
performed using a standard conversion table. Standard error is
calculated as !(1/gw). *Suggestive (P,8610
24), **Significant
(P,2.6610
-5).
Found at: doi:10.1371/journal.pone.0014186.s002 (0.03 MB
DOC)
Table S3 Derived meta-analysis effect sizes summarised by
agent/route. Weighted mean r (6 s.e.m) for combined BXD and
F2s data which is subsequently combined by route and by agent (see
methods). *Suggestive (P,8610
24), **Significant (P,2.6610
25).
Found at: doi:10.1371/journal.pone.0014186.s003 (0.04 MB
DOC)
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